Table 1.

Patient and tumor characteristics of the samples used for scRNA-seq

Sample ID	Tumor site	Pathological staging of cancers		P16 Immunostain	HPV in situ hybridization	Ethnicity	Sex	Diagnosis	Age, y (in 2019)
		T (primary tumor)	N (metastatic node)
S-SCC-7202	Oral cavity	pT3	pN2c	Positive	N.A.	Asian	F	New diagnosis	49
S-SCC-7204	Oropharynx	pT2	pN2	Positive	N.A.	White	M	New diagnosis	43
S-SCC-7205	Oral cavity	pT2	pN2b	Negative	Positive for high-risk HPV	White	F	New diagnosis	72
S-SCC-7207	Oropharynx	pT1	pN0	Positive	N.A.	White	M	New diagnosis	83
S-SCC-7211	Oral cavity	pT4a	pN3b	Negative	N.A.	Asian	M	New diagnosis	73
S-SCC-7257	Oral cavity	pT3	pN2b	N.A.	N.A.	White	M	New diagnosis	62
S-SCC-7267	Oral cavity	pT4a	pN3	Negative	N.A.	Other (non-Hispanic or Latino)	M	New diagnosis	57
S-SCC-7329	Oral cavity	pT4a	pN1	Negative	N.A.	Hispanic or Latino	M	New diagnosis	51

N.A., not available.